Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Sell
40
MNTL Quote, Financials, Valuation and Earnings
Last price:
$24.69
Seasonality move
:
--
Day range:
$24.69 - $24.69
52-week range:
$23.67 - $27.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
113
Avg. volume:
--
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
$24.67 | -- | -- | -- | $0.26 | 0% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$25.62 | -- | -- | -- | $0.01 | 0% | -- |
|
CANC
Tema Oncology ETF
|
$24.94 | -- | -- | -- | $0.96 | 2.92% | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
$25.57 | -- | -- | -- | $0.11 | 0.44% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$29.39 | -- | -- | -- | $0.47 | 0.49% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | 0.000 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.140 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 1.218 | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | 1.072 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.482 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
Tema Neuroscience and Mental Health ETF vs. Competitors
-
Which has Higher Returns MNTL or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About MNTL or BMED?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is MNTL or BMED More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or BMED?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or BMED?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns MNTL or CANC?
Tema Oncology ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About MNTL or CANC?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Tema Oncology ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is MNTL or CANC More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or CANC?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Tema Oncology ETF offers a yield of 2.92% to investors and pays a quarterly dividend of $0.96 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or CANC?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns MNTL or FMED?
Fidelity Disruptive Medicine ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Fidelity Disruptive Medicine ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- -
What do Analysts Say About MNTL or FMED?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Disruptive Medicine ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Fidelity Disruptive Medicine ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Fidelity Disruptive Medicine ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 FMEDFidelity Disruptive Medicine ETF0 0 0 -
Is MNTL or FMED More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Fidelity Disruptive Medicine ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or FMED?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Fidelity Disruptive Medicine ETF offers a yield of 0.44% to investors and pays a quarterly dividend of $0.11 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Fidelity Disruptive Medicine ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or FMED?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Fidelity Disruptive Medicine ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Fidelity Disruptive Medicine ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Fidelity Disruptive Medicine ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Fidelity Disruptive Medicine ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- --
-
Which has Higher Returns MNTL or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is MNTL or HRTS More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or HRTS?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Where Will Cisco Systems Stock Be in 10 Years?
Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 9
IonQ [IONQ] is down 38.82% over the past day.
Sell
40
QMCO alert for Jan 9
Quantum [QMCO] is down 30.08% over the past day.
Sell
47
MATW alert for Jan 9
Matthews International [MATW] is up 14.21% over the past day.
